But the emerging consensus about Zetia has been striking: The majority of cardiologists interviewed at the American College of Cardiology meeting foresee a pullback in use of the drug until there is more science about how exactly it works.
But if it were duplicated elsewhere, that would raise questions about how some of the most vulnerable patients in the medical system are being treated, and how seriously some doctors take the tools that scienceworks hard to deliver to them.
That these abstractions then formed the basis of profound discoveries about how the world actually works is one of the fundamentally weird things about science.